Pharming Group, Sanofi Renew Strategic Manufacturing Partnership Agreement
23 Dezember 2021 - 11:02AM
Dow Jones News
By Kyle Morris
Pharming Group NV said Thursday that it has renewed its
strategic manufacturing partnership with Sanofi SA.
The Dutch pharmaceutical company said that, as a result of the
extended five-year contract, it has decided to no longer continue
with its plans for its own downstream production capacity at Pivot
Park in Oss in the Netherlands, saving it around $40 million.
"As a result of this renewed manufacturing partnership, we can
now fully focus on our core competencies; the development and
commercialization of our products and investing our human and
financial capital in pursuing additional near-term growth
opportunities through the in-licensing or acquisition of late-stage
products," Chief Executive Sijmen de Vries said.
Write to Kyle Morris at kyle.morris@dowjones.com
-0-
(END) Dow Jones Newswires
December 23, 2021 04:47 ET (09:47 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Pharming Group NV (EU:PHARM)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Pharming Group NV (EU:PHARM)
Historical Stock Chart
Von Apr 2023 bis Apr 2024